High CEO Pay Equals Low Corporate Performance: GMO Report
A savvy portfolio manager wants to buy shares of companies focused like a laser beam on maximizing shareholder value, right? Not so, says GMO.
2010 Q4 Earnings: Fiserv Revenue Edges Up, Profit Edges Down
Fiserv reported Thursday modest increases in revenue for the fourth quarter and for full-year 2010.
New drug developments, partnerships and clinical-trial results could propel the sector this year, analysts say. --- Larry NeiborRobert W. Baird & Co. firstname.lastname@example.org Area of coverage: Specialty Pharmaceuticals Sector...